152 related articles for article (PubMed ID: 37863815)
21. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
22. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma.
Yan X; Qiu Y
Cancer Lett; 2016 Sep; 379(2):220-4. PubMed ID: 26282785
[TBL] [Abstract][Full Text] [Related]
23. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
24. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
Llovet JM; Fuster J; Bruix J;
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
[TBL] [Abstract][Full Text] [Related]
25. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
27. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
28. A machine learning method for improving liver cancer staging.
Zhao Z; Tian Y; Yuan Z; Zhao P; Xia F; Yu S
J Biomed Inform; 2023 Jan; 137():104266. PubMed ID: 36494059
[TBL] [Abstract][Full Text] [Related]
29. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
Hsu CY; Liu PH; Ho SY; Hsia CY; Kudaravalli P; Lee YH; Chiou YY; Tsai YJ; Huang YH; Huo TI
BMC Cancer; 2018 Mar; 18(1):289. PubMed ID: 29540157
[TBL] [Abstract][Full Text] [Related]
30. A proposed modification for the Barcelona Clinic Liver Cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
[TBL] [Abstract][Full Text] [Related]
31. A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma.
Kawakita T; Shiraki K; Yamanaka Y; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Okano H; Sugimoto K; Murata K; Yamakado K; Takeda K; Nakano T
Int J Oncol; 2003 Oct; 23(4):1115-20. PubMed ID: 12963993
[TBL] [Abstract][Full Text] [Related]
32. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
[TBL] [Abstract][Full Text] [Related]
33. Changed clinical aspects of primary liver cancer in China during the past 30 years.
Yang BH; Xia JL; Huang LW; Tang ZY; Chen MS; Li JQ; Liang AM; Mo QG; Lu HS; Dai CL; Yan LN; Yu ZJ; Rao RS; Li LQ; Su ZX; Fang ZW
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):194-8. PubMed ID: 15138108
[TBL] [Abstract][Full Text] [Related]
34. Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.
Varela M; Sala M; Llovet JM; Bruix J
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():98-102. PubMed ID: 12786620
[TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
36. A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma.
Liu Y; Sun L; Gao F; Yang X; Li Y; Zhang Q; Zhu B; Niu S; Huang Y; Hu Y; Feng Y; Jiang Y; Wang X
Medicine (Baltimore); 2018 Dec; 97(49):e13536. PubMed ID: 30544459
[TBL] [Abstract][Full Text] [Related]
37. [STAGING SYSTEMS OF HEPATOCELLULAR CARCINOMA].
Tumanova UN; Shchegolev AI
Eksp Klin Gastroenterol; 2016; (7):121-8. PubMed ID: 30284434
[TBL] [Abstract][Full Text] [Related]
38. Prognostic prediction in patients with hepatocellular carcinoma.
Sala M; Forner A; Varela M; Bruix J
Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
[TBL] [Abstract][Full Text] [Related]
39. The challenge of prognosis and staging for hepatocellular carcinoma.
Marrero JA; Kudo M; Bronowicki JP
Oncologist; 2010; 15 Suppl 4():23-33. PubMed ID: 21115578
[TBL] [Abstract][Full Text] [Related]
40. Improved prognostic prediction model for liver cancer based on biomarker data screened by combined methods.
Su Z; Li C; Fu H; Wang L; Wu M; Feng X
Math Biosci Eng; 2023 Jan; 20(3):5316-5332. PubMed ID: 36896547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
